Skip to main content
Displaying 25 - 36 of 60
Display:
12
24
48
General Hepatology
Introduction
Webcasts
View
General Hepatology
Refining prediction of survival after TIPS using a new index of post-TIPS survival
Webcasts
View
Metabolism, Alcohol & Toxicity
Session 1: Identifying Patients with NASH and Significant Fibrosis: Are we doing enough?
Webcasts
View
Metabolism, Alcohol & Toxicity
Session 2: Managing patients with NASH and Significant Fibrosis – Now and in the future
Webcasts
View
Metabolism, Alcohol & Toxicity
Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?
Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Welcome and a journey back to 1992
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Personal perspectives: What is the most significant advance in the last 10 years?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Snapshot in 2022 and beyond: Where are we now and what do we need to achieve?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Personal priorities
Webcasts
View
General Hepatology
What is the impact of cholestatic liver disease on the patient?
Webcasts
View
General Hepatology
Management of cholestatic liver diseases
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Current page
3
Page
4
Page
5
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy